Tech Company Financing Transactions
BioXell SpA Funding Round
BioXell SpA closed a $13.5 million Series C funding round on 3/15/2006. Backers included TVM Capital and Index Ventures.
Transaction Overview
Company Name
Announced On
3/15/2006
Transaction Type
Venture Equity
Amount
$13,475,200
Round
Series C
Investors
TVM Capital (Lead Investor) (Hubert Birner)
Proceeds Purpose
The additional funds give us the flexibility to tap the public markets at some time in the future, and enable us to continue to focus on adding value to the Company by advancing compounds into development.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Via Fratelli Cervi Centro Direzionale di Milano 2 Palazzo Va
Segrate, 20090
Italy
Segrate, 20090
Italy
Phone
Website
Email Address
Overview
BioXell is a private biopharmaceutical company with offices in Milan, Italy, and Nutley, NJ, USA spun-off from Roche in March 2002.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Niels Ackermann
Browse more venture capital transactions:
Prev: 3/15/2006: Sipera Systems venture capital transaction
Next: 3/15/2006: Luxtera venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs